MedTrace Logo

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

NCT04849637 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2022-03-08

No results posted yet for this study

Summary

This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)

Conditions

  • Covid19

Interventions

DRUG

Virgin Coconut Oil

Oral supplementation of virgin coconut oil to COVID-19 patients

Sponsors & Collaborators

  • Philippine Coconut Authority

    collaborator UNKNOWN

  • Philippine Council for Health Research & Development

    collaborator OTHER_GOV

  • University of the Philippines

    lead OTHER

Principal Investigators

  • Marissa M Alejandria, MD · UP Manila

  • Leslie Michelle M Dalmacio, PhD · UP Manila

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2022-04-09
Completion
2022-04-09

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04849637 on ClinicalTrials.gov